"Curcumin inhibits anti-apoptotic proteins-induced myeloid leukemia cell differentiation protein (Mcl-1) and X-linked inhibitor of apoptosis protein (XIAP), and upregulates the pro-apoptotic protein Bcl-2-like protein 11 (BIM)"
https://www.sciencedirect.com/science/article/pii/S222116911730494X
"There is compelling evidence that curcumin can inhibit leukemia cancer cell growth and enhance the effectiveness of the chemotherapy. Quercetin has even more evidence for beneficial use against leukemia. The most important factor is absorption."
https://www.newsmax.com/Health/Dr-Blaylock/article/2012/05/14/id/482654/
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673136/
Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG
https://pubmed.ncbi.nlm.nih.gov/19228728/
Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling
https://pubmed.ncbi.nlm.nih.gov/31854220/
Curcumin as a therapeutic agent in leukemia
https://pubmed.ncbi.nlm.nih.gov/30609023/